Pharmabiz23h
SpringWorks to present long-term efficacy and safety data from phase 3 DeFi trial of Ogsiveo in adults with desmoid tumours at CTOS 2024 meeting
SpringWorks to present long-term efficacy and safety data from phase 3 DeFi trial of Ogsiveo in adults with desmoid tumours at CTOS 2024 meeting: Stamford, Connecticut Saturday, N ...
Pharmabiz1d
Adaptive Biotechnologies get expanded medicare coverage of clonoSEQ for assessing measurable residual disease in mantle cell lymphoma
Adaptive Biotechnologies get expanded medicare coverage of clonoSEQ for assessing measurable residual disease in mantle cell lymphoma: Seattle Saturday, November 9, 2024, 15:00 Hr ...
Pharmabiz1d
Serres Group receives €1.8 million research grant from Business Finland
Serres Group receives €1.8 million research grant from Business Finland: Espoo, Finland Saturday, November 9, 2024, 16:00 Hrs [IST] Serres has been granted a substantial researc ...
Pharmabiz1d
Dizal seeks US FDA approval for sunvozertinib to treat relapsed or refractory NSCLC with EGFR Exon 20 insertion mutations
Dizal seeks US FDA approval for sunvozertinib to treat relapsed or refractory NSCLC with EGFR Exon 20 insertion mutations: Shanghai, China Saturday, November 9, 2024, 17:00 Hrs [I ...
Pharmabiz1d
AskBio receives US FDA rare paediatric disease & orphan-drug designations for AB-1003 to treat limb-girdle muscular dystrophy type 2I/R9
Research Triangle Park, North Carolina Saturday, November 9, 2024, 13:00 Hrs [IST] ...
Pharmabiz2d
Centre launches scheme for strengthening of medical device industry
Centre launches scheme for strengthening of medical device industry: Our Bureau, New Delhi Friday, November 8, 2024, 17:10 ...
Pharmabiz2d
Feinstein Institutes awarded Lupus Research Alliance funding for vagus nerve stimulation clinical trial
Feinstein Institutes awarded Lupus Research Alliance funding for vagus nerve stimulation clinical trial: New York Friday, November 8, 2024, 15:00 Hrs [IST] Systemic lupus erythema ...
Pharmabiz1d
Transgene & NEC to present new data confirming clinical proof of principle for neoantigen cancer vaccine, TG4050, in head & neck cancer at SITC 2024
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation, a leader in IT, network and AI technologies, announced 24.1 month ...
Pharmabiz1d
KPPA to organize webinar series from November 17 to 23 as part of NPW celebration
As part of the National Pharmacy Week (NPW) celebration, the Kerala Private Pharmacist Association (KPPA) is organizing a high-impact webinar series from November 17th to 23rd, connected by the common ...
Pharmabiz1d
MGI Tech partners with Human Cell Atlas to advance human cell mapping efforts globally
MGI Tech partners with Human Cell Atlas to advance human cell mapping efforts globally: Shenzhen, China Saturday, November 9, 2024, 12:00 Hrs [IST] MGI Tech Co., Ltd, a company co ...
Pharmabiz1d
US FDA grants 510(k) clearance to Bayer’s MEDRAD Centargo CT Injection System
US FDA grants 510(k) clearance to Bayer’s MEDRAD Centargo CT Injection System: Berlin Saturday, November 9, 2024, 09:00 Hrs [IST] Bayer, a global enterprise with core competenci ...
Pharmabiz2d
Prof Meritxell Huch, director at MPI-CBG, Germany receives this year’s Otto Bayer Award for pioneering research on human organoids
CBG, Germany receives this year’s Otto Bayer Award for pioneering research on human organoids: Leverkusen Friday, November 8, ...